ArticleTranslational cancer research2023

m6A reading protein RBMX as a biomarker for prognosis and tumor progression in esophageal cancer.

Hainisayimu Tuersun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.